7.29
price down icon4.08%   -0.31
after-market 시간 외 거래: 7.20 -0.09 -1.23%
loading

Xilio Therapeutics Inc (XLO) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
135.85%
19.07
8.084 2.93 1.724 2.263
Operating Expenses
6.48%
21.00
22.45 16.78 15.35 17.02
Benefits Costs and Expenses
-
- 16.20 14.82 -
Costs And Expenses
6.48%
21.00
22.45 16.20 14.82 17.02
Operating Income/Loss
86.57%
-1.929
-14.37 -13.85 -13.63 -14.76
Nonoperating Income/Loss
871.45%
-14.36
-1.478 0.586 0.536 0.742
Income/Loss From Continuing Operations Before Tax
135.85%
19.07
8.084 -13.27 -13.09 2.263
Income/Loss From Continuing Operations After Tax
2.80%
-16.29
-15.84 -13.27 -13.09 -14.02
Net Income/Loss
2.80%
-16.29
-15.84 -13.27 -13.09 -14.02
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
49.41%
144.11
96.45 74.70 3.7486 63.47
Basic Earnings Per Share
31.25%
-0.11
-0.16 -0.18 -0.18 -0.22
Diluted Earnings Per Share
31.25%
-0.11
-0.16 -0.18 -0.18 -0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):